What is your preferred regimen for treating pediatric patients with intermediate risk Hodgkin lymphoma: AHOD0031 or POG9425?
AHOD0031 may avoid radiation; however, has potential for more chemotherapy toxicity. On POG9425 everyone receives radiation; however, patients may have less toxicity from chemotherapy. How do you weigh the risk vs benefit of each regimen?
Community PollStarted
What is your preferred regimen for treating pediatric patients with intermediate risk Hodgkins lymphoma?
19 physicians have voted
Join Mednetto vote and see how they answered.